Precision Medicine

Two Advisory Board research leaders discuss the current state of precision medicine – and what it will take for genomics to become part of routine care.

The lack of adequate EHR interoperability continues to hinder healthcare organizations ability to use patient data in care delivery, the report’s author said. 

A single investor is suing the biotech mogul and NantHealth, alleging violation of federal securities laws. Other law firms have also filed class action suits against the company.

The report claims the biotech mogul used charitable donations to benefit his health tech company.

Varian will use the Linguamatics Health platform to extract unstructured concepts from within pathology reports and convert them to discrete data for analytics within Varian 360 Oncology.  

‘In our industry, you have to keep innovating,’ said Rometty about her experience at Big Blue for more than three decades.

The analytics and machine learning algorithms help a quadriplegic patient regain movement. 

Big Blue also announced value-based care solutions, Watson Health consulting services and a partnership with Atrius Health.

Intermountain is using genomics to attack the Darwinian nightmare.

UC Berkeley brought the case against Broad Institute in Jan. 2016, challenging the intellectual rights over patents held by Broad Institute for the gene editing technology. While Broad was first awarded patents for the technology, UC Berkeley claimed it was first to apply for the patent.